LGALS9 and glioblastoma: Glioblastoma multiforme-derived exosome LGALS9 can play a significant regulatory role in tumor progression by inhibiting dendritic cell antigen presentation and cytotoxic T cell activation in CSF; if this inhibition is lost, it can lead to long-lasting systemic anti-tumor immunity [28].